BOD Science Ltd (BOD) - Total Liabilities
Based on the latest financial reports, BOD Science Ltd (BOD) has total liabilities worth AU$7.75 Million AUD (≈ $5.48 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore BOD net assets growth trend to track the company's year-over-year net asset growth rate.
BOD Science Ltd - Total Liabilities Trend (2016–2025)
This chart illustrates how BOD Science Ltd's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does BOD Science Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
BOD Science Ltd Competitors by Total Liabilities
The table below lists competitors of BOD Science Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
AGS Transact Technologies Limited
NSE:AGSTRA
|
India | Rs-5.35 Billion |
|
Citrus Plant5-L
TA:CTPL5
|
Israel | ILA18.92 Million |
|
QMC Quantum Minerals Corp
V:QMC
|
Canada | CA$3.70 Million |
|
Apex Resources Inc
V:APX
|
Canada | CA$1.11 Million |
|
Beauce Gold Fields Inc
V:BGF
|
Canada | CA$762.09K |
|
Public Policy Holding Company Inc
LSE:PPHC
|
UK | GBX133.63 Million |
|
P/F Atlantic Petroleum
CO:ATLA-DKK
|
Denmark | Dkr121.83 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down BOD Science Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see BOD Science Ltd stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.34 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.50 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 2.98 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BOD Science Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BOD Science Ltd (2016–2025)
The table below shows the annual total liabilities of BOD Science Ltd from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$7.75 Million ≈ $5.48 Million |
+1.65% |
| 2024-06-30 | AU$7.63 Million ≈ $5.40 Million |
+81.24% |
| 2023-06-30 | AU$4.21 Million ≈ $2.98 Million |
+127.83% |
| 2022-06-30 | AU$1.85 Million ≈ $1.31 Million |
+9.17% |
| 2021-06-30 | AU$1.69 Million ≈ $1.20 Million |
-58.81% |
| 2020-06-30 | AU$4.11 Million ≈ $2.91 Million |
+188.16% |
| 2019-06-30 | AU$1.43 Million ≈ $1.01 Million |
+17.65% |
| 2018-06-30 | AU$1.21 Million ≈ $857.13K |
+99.66% |
| 2017-06-30 | AU$606.72K ≈ $429.29K |
+503.57% |
| 2016-06-30 | AU$100.52K ≈ $71.13K |
-- |
About BOD Science Ltd
Bod Science Limited operates as a cannabis focused drug development and product innovation company in Australia, the United Kingdom, the European Union, and the United States. The company operates through four segments: Medical, Over The Counter (OTC) Cannabidiol/Hemp, OTC Herbals, and Corporate. It engages in the development of cannabidiol and hemp products for consumers; and development and dis… Read more